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EVALUATING THE BENEFITS WITH TELECARE AMONG RESIDENTS IN 
NURSING HOMES IN TAIWAN
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1Taipei Medical University, Taipei, Taiwan; 2Hsiao Chung-Cheng Hospital, Taipei, Taiwan; 3Taipei 
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OBJECTIVES: The skyrocketing cost of health care is a crucial issue in Taiwan. This 
study aimed to evaluate a demonstrative project launched in 2008 whether a telecare 
management program (T-Care) via internet-based medical tele-consulting, tele-physi-
ological monitoring and health education services, could reduce medical utilization by 
patients with chronic cardiovascular disease or diabetes mellitus. METHODS: Study 
subjects were 102 patients residing in two nursing homes located in Keelung City and 
Taoyuan County, Taiwan. These residents received telecare management services from 
a district hospital in Taipei County during 2008. National Health Insurance (NHI) 
Claims data in 2007 and 2008 were gathered on medical utilization. The pre- and 
post- intervention effects were examined by comparing monthly utilization on inpa-
tient care, outpatient care, emergency rooms care using Two-Part models. Unscheduled 
medical services were deﬁ ned as utilization of emergency care or inpatient care. 
RESULTS: Signiﬁ cant decreases were found in the monthly probability of seeking any 
outpatient visit (92.1 vs. 85.6, P = 0.0035), but decrease in the monthly probability 
of seeking any emergency care or any inpatient care were not signiﬁ cant. For users of 
each speciﬁ c care, decrease in number of monthly hospitalizations (1.13 vs. 1.10, P = 
0.0987) and number of monthly emergency room visits (1.25 vs. 1.11, P = 0.0547) 
were found, but decreases in outpatient visits was not signiﬁ cant. Decreases in the 
total unscheduled NHI resource costs were found (14,548 vs. 14,403). The estimated 
total annual savings from unscheduled medical services for the study subjects were 
estimated to be NT$177,627(1 US$ = 31.91 NT$ in 2008). CONCLUSIONS: T-Care 
may reduce medical costs in patients residing in the nursing homes with reduced rates 
of readmission to the hospital. Larger clinical trials with larger sample size and con-
trols are warranted to determine the beneﬁ ts of the T-care. 
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THE IMPACT OF METABOLIC SYNDROME ON QUALITY OF LIFE AND 
RESOURCE USE IN CHINA AND THE UNITED STATES
DiBonaventura MD1, Liu GG2, Wagner JS1, Stankus A3
1Kantar Health, New York, NY, USA; 2Peking University, Beijing, China; 3Kantar Health, 
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OBJECTIVES: The objective of this study was to better understand the health out-
comes of patients with metabolic syndrome in China and the United States. 
METHODS: This study utilized data from two large, cross-sectional, Internet-based 
survey databases: the 2009 US and 2009 China National Health and Wellness Surveys 
(NHWS). Patients were deﬁ ned as having metabolic syndrome if they met three of the 
following conditions: having a body mass index greater or equal to 30, a diagnosis of 
high cholesterol, hypertension, or diabetes. Patients who met these criteria were then 
compared with those who did not (controls) on health-related quality of life (physical 
component summary (PCS) scores of the SF-12v2), the number of emergency room 
(ER) visits in the last 6 months, and the number of hospitalizations in the last 6 
months, controlling for demographics (country, age, gender, ethnicity, income, educa-
tion) and patient characteristics (BMI and Charlson comorbidity index). RESULTS: 
A total of 10,339 patients (13.68%) in the United States and 79 patients (0.59%) in 
China were classiﬁ ed as having metabolic syndrome. After controlling for demograph-
ics and patient characteristics, those with metabolic syndrome reported signiﬁ cantly 
lower levels of PCS relative to controls (Madj = 43.4 vs. 48.0, P < 0.0001). This effect 
was consistent between the United States and China. Across both countries, control 
patients reported signiﬁ cantly more ER visits than metabolic syndrome patients (b = 
−0.01, P = 0.02). However, this effect was largely due to the effect observed in the 
United States. Metabolic syndrome patients reported signiﬁ cantly more ER visits than 
controls in China (Madj = 1.42.vs. 0.41, P < 0.0001). CONCLUSIONS: While patients 
in the United States were more likely to have metabolic syndrome relative to China, 
quality of life effects were similar in the two countries and there was a signiﬁ cantly 
greater disparity in ER visits between metabolic syndrome patients and controls in 
China than the United States. 
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PATTERN OF LIPID MODIFYING AGENTS PRESCRIPTION AMONG 
CLUSTERS OF PHYSICIAN IN A THAI TEACHING HOSPITAL, FISCAL 
YEAR 2009
Kaojarern S, Ongphiphadhanakul B, Pattanaprateep O
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
OBJECTIVES: Lipid modifying agents (7.63% of total drug expenditure in 2009) were 
prescribed by several specialists in a Thai teaching hospital. Cluster analysis was 
applied to group prescribing physicians by drug cost. Pattern of prescription among 
clusters were studied. METHODS: Data of drugs in Anatomical Therapeutic Chemical 
class C10 (lipid modifying agents) were retrieved from a hospital database, and 
unidentiﬁ ed physician records (1758 from 205,964) were deleted. Drug cost for each 
prescribing physician was the summation of C10 drug issued quantity multiplied by 
unit cost at selling price. Drug costs for each physician were then grouped by hierarchi-
cal clustering. Pattern of prescribed drug among clusters was analyzed after classifying 
lipid lowering agents into four types i.e., brand statins, brand non-statins, generic 
statins, and generic non-statins. RESULTS: Prescribing physicians were grouped into 4 
clusters; one gynecologist in the ﬁ rst; two internists in the second; four internists, one 
family medicine doctor, one gynecologist in the third and the rest in the fourth cluster. 
Pattern of C10 drugs was 76.2% brand statins, 19.1% brand non-statins, 3.3% generic 
statins, and 1.4% non-statins. In the ﬁ rst cluster, 97.3% of the 13.3 million Baht was 
from brand stains. For the second cluster, 9.15 and 9.88 million Baht was each prescribed 
by two doctors with 65.7% from brand statins and 32.2% from brand non-statins. 
Distribution of drug type in the third cluster was similar to that in the fourth. However, 
average drug expenditure was higher in the third cluster than the fourth (6.11 million vs. 
0.14 million Baht). CONCLUSIONS: Patterns of prescribing behavior of lipid modify-
ing agents can be identiﬁ ed through cluster analysis of prescription database. The 
result can be helpful for the further study of factors accountable for marked deviation 
from common patterns. 
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ADHERENCE TO ANTIHYPERTENSIVE MEDICATIONS: A QUALITATIVE 
STUDY AMONG OUTPATIENTS VISITING PUBLIC HOSPITALS IN THE 
CITY OF QUETTA, PAKISTAN
Saleem F1, Hassali MA2, Shaﬁ e AA2
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OBJECTIVES: The main aim of this study is to examine the perception of hypertensive 
patients toward adherence toward their medication in actual practices. DESIGN: 
Qualitative In Depth Interviews. SETTINGS: Hypertensive patients visiting public 
hospitals in Quetta City, Pakistan. METHODS: A qualitative approach was used. A 
purposive sample of patients with known diagnosis of hypertension attending public 
hospitals in Quetta City, Pakistan were interviewed using a semi-structured interview 
guide. All the interviews were transcribed verbatim and were thematically analyzed. 
RESULTS: Thematic content analysis yielded ﬁ ve major themes: 1) perceived beneﬁ ts 
and risk of drugs; 2) physician attitude and general behavior; 3) perception toward 
traditional remedies; 4) general ideology toward drugs; and 5) believes toward hyper-
tension and its control. A number of patients had speciﬁ c and consistent reservations 
regarding drug usage in general regardless to the nature of disease or condition. Drug 
usage and adherence was connected to physician’s attitude and past experiences, 
beneﬁ ts and risk assessment and knowledge related to hypertension and its treatment. 
Patients expressed multiple reservations against drug usage and non usage that 
reﬂ ected the level of knowledge toward drugs and disease in the community. CON-
CLUSIONS: The ﬁ ndings suggested that, patients interviewed were more focus on 
alternative treatments for controlling their hypertension and if the initial treatment 
fails then only they will seek attention at the hospitals. Factors such as physician 
attitude, past experiences and knowledge related to hypertension also plays a key role 
in medication adherence. In general, adherence to medication seems to be poor and 
need to be enhanced. Beside that knowledge toward hypertension causes and treatment 
is also very poor among patients interviewed and these need to be addressed for a 
successful treatment outcome. 
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HEALTH-RELATED QUALITY OF LIFE AFTER PERCUTANEOUS 
CORONARY INTERVENTION IN PATIENTS WITH ACUTE 
CORONARY SYNDROMES
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OBJECTIVES: This study sought to investigate the health status outcomes (health-
related quality of life and utility weights) after percutaneous coronary intervention 
(PCI) in patients with acute coronary syndromes (ACS). METHODS: This was a 
prospective observational study targeted for the patients underwent PCI with ACS in 
48 tertiary hospitals. We assessed the ACS-speciﬁ c health status (with the use of the 
Seattle Angina Questionnaire [SAQ]) and the general health status (with the use of 
the EuroQOL Visual Analogue Scale [EQ-VAS] and EuroQOL 5-Dimensional Clas-
siﬁ cation [EQ-5D]) within 1 week after PCI. RESULTS: A total number of 349 
patients were included; average 63.4 aged, 67.3% male, 82.2% non-ST-segment eleva-
tion ACS (NSTE ACS). The mean (±SD) SAQ scores (which range from 0 to 100, with 
higher scores indicating better health status) were 78 ± 23 for physical limitations, 41 
± 30 for angina stability, 70 ± 24 for angina frequency, 77 ± 14 for treatment satisfac-
tion, and 48 ± 19 for quality of life. Analyzing by diagnosis class, NSTE ACS patients 
had the signiﬁ cant lower scores in all SAQ domains than STE ACS. The other health 
status outomes, mean (±SD) EQ-VAS scores (which range from 0 to 100) were 70 ± 
19 and mean (±SD) EQ-5D scores (which mean utility weights, and range from 0 to 
1) were 0.80 ± 0.28. In utility weights, NSTE ACS patients (0.78 ± 0.29) also revealed 
the lower scores than STE ACS (0.87 ± 0.23). The utility weights of female (0.82 ± 
0.28) is lower than those of male (0.82 ± 0.28), and older patients showed lower 
utility weights (<55 aged: 0.89 ± 0.24, 55~64: 0.81 ± 0.26, 65~74: 0.76 ± 0.31, 0.71 
± 0.29). CONCLUSIONS: The health status outcomes of disease-speciﬁ c measure and 
general measure showed similar tendency. Further follow up survey is needed to 
explore the health-related quality of life among ACS patients underwent PCI. 
Comment: The results were described based on the interim results of KOREAN 
MUSTANG study. The ﬁ nal result will be applied and modiﬁ ed before presentation. 
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DESIGN OF A DISCRETE CHOICE EXPERIMENT TO QUANTIFY 
CONSUMER PREFERENCES FOR CHRONIC HEART FAILURE 
MANAGEMENT PROGRAMS
Whitty JA1, Scuffham PA1, Marwick T2, Carrington M3, Stewart S3
1Grifﬁ th University, Meadowbrook, Queensland, Australia; 2University of Queensland, 
Brisbane, Queensland, Australia; 3Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, 
Australia
BACKGROUND: Consumer preferences are important to inform the efﬁ cient and 
responsive delivery of health-care services; particularly for the chronically ill. Chronic 
Heart Failure Management Programs (CHF-MPs) are effective at reducing morbidity 
and mortality and are arbitrarily applied in different ways and settings. We know very 
little of consumer preferences surrounding the choice between CHF-MPs applied via 
the patient’s home or a specialist hospital clinic. The Discrete Choice Experiment 
(DCE) offers a method to systematically quantify the relative importance of different 
characteristics of a CHF-MP, from the patient’s perspective. OBJECTIVES: To 
describe the development of a DCE to quantify consumer preferences related to CHF-
MPs. METHODS: A series of 12 semi-structured interviews were undertaken with 
patients enrolled in a clinical trial comparing home and clinic based CHF-MPs (the 
WHICH? Study). Interviews explored the characteristics of a CHF-MP which were 
important to patients. These characteristics were then used as a basis for the design 
of the DCE instrument. A fractional factorial blocked design capable of estimating all 
main and one two-way interaction effect was utilized. RESULTS: Key themes identi-
ﬁ ed by interview participants included delivery, communication, education, and nur-
turing. A CHF-MP DCE instrument was developed describing CHF-MPs in terms of 
characteristics including whether the same nurse is seen at each visit, the cost (includ-
ing travel costs) of seeing the nurse, and access to telephone or exercise/education 
support services. The DCE will now be pilot-tested before being used to elicit the 
preferences of approximately 300 patients enrolled in the WHICH? Study. CONCLU-
SIONS: Interviews with CHF patients suggest consumers value aspects of a manage-
ment program beyond those directly related to health outcomes. The DCE designed 
from this process will be capable of quantifying preferences and estimating willingness-
to-pay for the process-based characteristics of a CHF-MP. 
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PERCEPTION OF PATIENTS ON WARFARIN THERAPY TOWARD 
PHARMACIST-MANAGED ANTICOAGULATION SERVICE IN 
AMBULATORY CARE SETTINGS IN SINGAPORE
Lee JYC1, Chen C1, Ko Y1, Lee E2, Lee SK2
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OBJECTIVES: Patient perception has been shown to affect the success of pharmacist-
managed clinics such as the anticoagulation clinic (ACC). However, such ﬁ ndings are 
yet to be elucidated in Singapore. The primary objective of this study was to assess 
patients’ perceptions and acceptance of pharmacist-managed ACC in the primary care 
settings in Singapore. The secondary objective was to identify factors that may affect 
patient satisfaction and knowledge on warfarin therapy. METHODS: This was a 
cross-sectional, quality assurance, telephone survey conducted from September to 
December 2009. All patients referred to the pharmacists-managed ACC from nine 
primary care institutions for at least one visit were included, and those with hearing 
disability were excluded. The questionnaire was administered mainly in English, 
Chinese or Malay, and consisted of three sections: 1) patient demographics, 2) a 
20-item, ﬁ ve-point likert scale patient satisfaction questions, and 3) a ﬁ ve-item war-
farin knowledge questions. RESULTS: A total of 149 (39.9%) surveys were eligible 
for analysis. Questions categorized into Friendly Explanation and Managing Therapy 
had mean scores of 3.64 ± 0.55 and 3.54 ± 0.60, respectively. Gender, ethnicity, educa-
tion level and age were not associated with patient satisfaction. Age (p = 0.03) and 
education level (p = 0.01) were negatively and positively correlated with warfarin 
knowledge, respectively. CONCLUSIONS: Overall, patients found the ACC pharma-
cists to be friendly and were satisﬁ ed with the management of the service. Patient 
demographics did not associate with patient satisfaction. Age and education level, 
however, showed to affect warfarin knowledge. 
PCV31
BASELINE HEALTH-RELATED QUALITY OF LIFE STUDY IN 
HONG KONG CARDIAC PATIENTS UNDERGOING 
PERCUTANEOUS CORONARY INTERVENTION
Lee V, Yan B, Yu CM
The Chinese University of Hong Kong, Shatin, Hong Kong
OBJECTIVES: To investigate the baseline quality of life of Hong Kong cardiac 
patients who had undergone percutaneous coronary intervention (PCI) and the base-
line characteristics of these patients. METHODS: Eligible cardiac patients at the Prince 
of Wales Hospital during March to September 2009 were recruited into study while 
they were hospitalized for PCI. The generic short form 36 health survey (SF 36) and 
MacNew Heart Disease HRQL questionnaire were used to assess the patient’s baseline 
quality of life. Patients’ social and clinical characteristics were also recorded. 
RESULTS: One hundred patients were recruited (male: 81%; mean age: 62.06 
+/−10.14). The highest incidence of PCI occurred in the age group of 50–59s (30%). 
Smoking patients reported with lower mean scores indicating a poorer quality of life. 
The mean scores of the 8 health domains of SF 36 were physical functioning (PF) 
72.70, role physical (RP) 53.25, bodily pain (BP) 61.55, general health (GH) 49.83, 
vitality (VT) 47.85, social functioning (SF) 71.89, role emotional (RE) 72.67 and 
mental health (MH) 68.06. The mean physical component score (PCS) and mean 
mental component score (MCS) were 36.94 and 47.88, respectively. CONCLUSIONS: 
Risk factors including the male gender and advanced age contributed signiﬁ cantly to 
coronary heart disease. The presence of comorbidities, cigarette smoking, and long-
standing CHD requiring elective PCI also contributed toward a poorer quality of life. 
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COST-EFFECTIVENESS ANALYSIS OF DISEASE MANAGEMENT 
PROGRAM OF HYPERTENSION IN SHANGHAI, CHINA
Hu S
Fudan University, Shanghai, China
OBJECTIVES: To exploit whether disease management program (DMap) is cost-
effectiveness, improvement of quality and outcomes in hypertension intervention at 
community level. METHODS: Four districts were selected to conduct a quasi-exper-
imental study in 2006–2007. About 1442 hypertension patients were enrolled to 
management group (962 cases) and control group (480 cases). Patient blood pressure, 
behavior and lifestyles were surveyed at baseline and followed in 6 and 12 months. 
The cost data were collected from community health institution and disease managers 
by questionnaires. RESULTS: The cost per patient was 968.8 Yuan (RMB) ($143) in 
management group and 740.6 Yuan (RMB) ($109) in control group. The incremental 
cost per patient in management group was equal to 19 Yuan (RMB) ($2.8) per patient 
per month. After a 12-month follow-up, the average systolic blood pressure (SBP) was 
declined 7.96 mmHg and the average diastolic blood pressure (DBP), 4.5 mmHg in 
management group. The individual blood pressure before and after intervention 
matched pairs showed that the average SBP and DBP per patient was reduced 
12.95 mmHg and 7.89 mmHg,respectively. The results illustrate the effectiveness of 
controlling SBP and DBP in management group which is much better than that in 
control group (P < 0.01). However, the cost of declining 1mmHg DBP is much higher 
than the cost of declining 1 mmHg SBP. The incremental cost-effectiveness analysis 
(ICEA) showed that incremental cost for declining 1 mmHg SBP and DBP in manage-
ment group is less than that in control group (0.45 Yuan vs. 83 Yuan). CONCLU-
SIONS: DMap can improve the cost-effectiveness and quality of care in community 
hypertension intervention. The characteristics of DMap is to promote patient self-
management on hypertension by using participatory approach. Patients change their 
lifestyles (diet, smoking, physical exercise and compliance of medicines) so as to 
control their blood pressure. Finally, after 1-year best practice, DMap has been scale 
up to all districts in Shanghai since 2009. 
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THE IMPACT OF SWITCHING PATIENTS TO ROSUVASTATIN ON 
HEALTH-CARE EXPENDITURE AND PREVENTION OF 
CARDIOVASCULAR DISEASE: A COHORT STUDY
Lin W1, Chou LP2, Kuo C2
1Chang Jung Christian University, Tainan, Taiwan; 2Sin-Lau Hospital, the Presbyterian Church of 
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OBJECTIVES: To assess the impact on the health-care expenditure and prevention of 
hospitalization of cardiovascular disease (CVD) for beneﬁ ciaries of Taiwan’s National 
Health Insurance (NHI) scheme after rosuvastatin (RSV) become available in NHI’s 
beneﬁ t package in May, 2005. METHODS: Using NHI’s claim data of a nationally 
representative random sample (consisting of 1 million of eligible beneﬁ ciaries) from 
2004–2008, we classiﬁ ed patients > = 20 years of age who received other statins before 
and switched to RSV during May 2005 to April 2006 into switch group (N = 1,040). 
Other patients who received statins therapy except RSV before May 2005 and 
throughout 2008 were classiﬁ ed into control group. Using propensity score (PS), we 
selected match group (N = 1,039) from control group (N = 18,432) based on age, 
gender, prior ambulatory care expenditure, and comorbidities related to the probabil-
ity of switching. The date of ﬁ rst claim for prescribing RSV or other statins after May 
2005 was the index date. Cumulative health expenditure after 1, 2, and 3 years from 
index date were compared between switch group and match group. Cox regression 
model controlling for age, sex, and comorbidities was applied to investigate the rela-
tive risk of hospitalization for CVD between two groups. RESULTS: Patients who 
switched to RSV are signiﬁ cantly consumed more ambulatory care resources after 1-, 
2-, and 3-year of switching ($348, $680, and $1050 more, respectively). Before PS 
matching, the relative risk of hospitalization CVD in switch group is signiﬁ cantly 
higher than control group (RR = 1.38, 95% CI = 1.12–1.70). After PS matching, the 
relative risk is still higher than match group (RR = 1.18, 95% CI = 0.881.58), but 
with less signiﬁ cance. CONCLUSIONS: RSV may be more cost-effective in lowering 
low-density lipoprotein cholesterol, but when taking the prevention of CVD hospital-
ization into account, the cost-effectiveness is diminishing. Putting new drugs into 
coverage should be considered more rigorously when cost is higher but beneﬁ t is not 
substantive. 
